Congress trades

AptarGroup, Inc. (ATR)

NYSE · Healthcare · 16 congress trades · last filed 11 months ago

16
Congress disclosures shown
37d
Median delay on the congress disclosures
of the 45 day limit
9 buys·7 sells
Purchases and sales in the disclosures shown
Get a push when a member of Congress trades ATR.

Free on iOS and Android.

About AptarGroup, Inc.

from the company's filings and listing, as of Oct 22, 2026
Exchange
NYSE
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Chief executive
Gael Touya
Employees
14,000
Listed since
Apr 23, 1993
Market value
$8.0B
Price to earnings (12 mo)
22.4
Net income per share, as reported (12 mo)
$5.68
Dividend yield
1.53%

www.aptar.com

Earnings

6 reported quarters · next on Oct 29, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Jul 30, 2026$1.42$1.35$1.0B$1.0BEPS beatRevenue beat
Q1 FY2026reported Apr 30, 2026$1.19$1.15$982.9M$956.0MEPS beatRevenue beat
Q4 FY2025reported Feb 5, 2026$1.25$1.24$962.7M$878.6MEPS in lineRevenue beat
Q3 FY2025reported Oct 30, 2025$1.62$1.57$961.1M$880.2MEPS beatRevenue beat
Q2 FY2025reported Jul 31, 2025$1.66$1.58$966.0M$959.0MEPS beat, GAAPRevenue in line
Q1 FY2025reported May 1, 2025$1.20$1.16$887.3M$898.6MEPS beatRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for fiscal 2025 · proxy filed Mar 27, 2026
ExecutiveSalaryStock awardsOtherTotal
Stephan B. TandaPresident and Chief Executive Officer$1.2M$6.1M$3.0M$10.2M
Gael TouyaPresident, Aptar Pharma$653K$937K$2.0M$3.6M
Vanessa KanuExecutive Vice President and Chief Financial Officer$720K$2.0M$869K$3.6M
Hedi TliliPresident, Aptar Closures$620K$748K$1.3M$2.6M
Xiangwei GongExecutive Vice President, Strategic Group Development and President, Aptar Asia$569K$738K$1.1M$2.4M
Marc PrieurPresident, Aptar Beauty$722K$851K$668K$2.2M

The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesShares vs prior qtr% of shares out
BlackRock, Inc.$768.5M6,137,894+0.9%9.61%
State Farm Mutual Automobile Insurance Co$594.0M4,744,5640.0%7.43%
Vanguard Portfolio Management LLC$455.6M3,638,724-3.4%5.70%
Morgan Stanley$441.2M3,523,908+4.4%5.52%
Vanguard Capital Management LLC$362.3M2,893,751+0.3%4.53%
State Street Corp$358.5M2,863,390+2.8%4.47%
Victory Capital Management Inc$319.8M2,554,561+5.6%4.00%
Geode Capital Management, LLC$218.9M1,747,815+3.2%2.74%
Dimensional Fund Advisors LP$218.0M1,741,294+15.7%2.73%
Neuberger Berman Group LLC$193.9M1,548,824+31.9%2.43%
Fiduciary Management Inc$178.3M1,423,771+13.7%2.23%
River Road Asset Management, LLC$169.1M1,350,700+14.8%2.12%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

Know when the next ATR filing is reported.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in ATR

16 disclosures of 16 on record · median 37d of the 45 allowed

Since the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 24, 2026), not the member's result. Not investment advice.

MemberTypeActionAmount disclosedStock since the tradeTrade dateDisclosedDelay
Michael T. McCaulStockPurchase$15,001 - $50,000+7.3%S&P 500 +14.7% · -7.4 pts vs S&P 500Nov 19, 2025Dec 9, 202520d
Michael T. McCaulStockPurchase$1,001 - $15,000-7.7%S&P 500 +15.6% · -23.2 pts vs S&P 500Sep 11, 2025Oct 10, 202529d
Michael T. McCaulStockPurchase$15,001 - $50,000-4.6%S&P 500 +13.6% · -18.3 pts vs S&P 500Sep 22, 2025Oct 10, 202518d
Michael T. McCaulStockPurchase$15,001 - $50,000-9.9%S&P 500 +20.2% · -30.1 pts vs S&P 500Aug 7, 2025Sep 11, 202535d
Michael T. McCaulStockSale$1,001 - $15,000-10.0%After the saleS&P 500 +19.6% · -29.6 pts vs S&P 500Aug 21, 2025Sep 11, 202521d
Lisa C. McClainSpouseStockPurchase$1,001 - $15,000-17.8%S&P 500 +24.9% · -42.6 pts vs S&P 500Jun 24, 2025Aug 13, 202550d
Michael T. McCaulStockSale$1,001 - $15,000-15.7%After the saleS&P 500 +35.5% · -51.3 pts vs S&P 500Aug 26, 2024Sep 16, 202421d
Michael T. McCaulStockPurchase$15,001 - $50,000+2.9%S&P 500 +79.9% · -76.9 pts vs S&P 500Nov 1, 2023Dec 9, 202338d
Michael T. McCaulStockPurchase$1,001 - $15,000+2.9%S&P 500 +79.9% · -76.9 pts vs S&P 500Nov 1, 2023Dec 9, 202338d
Michael T. McCaulStockPurchase$50,001 - $100,000+18.0%S&P 500 +84.0% · -66.0 pts vs S&P 500Aug 8, 2022Sep 19, 202242d
Susie LeeJointStockSale$1,001 - $15,000+6.7%After the saleS&P 500 +153.3% · -146.6 pts vs S&P 500Sep 11, 2019Oct 21, 201940d
Susie LeeJointStockSale$1,001 - $15,000+6.9%After the saleS&P 500 +152.6% · -145.7 pts vs S&P 500Sep 13, 2019Oct 21, 201938d
Susie LeeJointStockSale$1,001 - $15,000+2.5%After the saleS&P 500 +153.0% · -150.5 pts vs S&P 500Jul 12, 2019Aug 29, 201948d
Lizzie FletcherSpouseStockSale$1,001 - $15,000+24.9%After the saleS&P 500 +172.0% · -147.1 pts vs S&P 500Feb 26, 2019Apr 23, 201956d
Bradley Scott SchneiderSpouseStockSale$250,001 - $500,000+24.7%After the saleS&P 500 +172.3% · -147.6 pts vs S&P 500Mar 5, 2019Apr 6, 201932d
Bradley Scott SchneiderSpouseStockPurchase$250,001 - $500,000+25.2%S&P 500 +178.2% · -153.0 pts vs S&P 500Feb 5, 2019Feb 17, 201912d

Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in ATR, filterable by party, chamber, type and account.

Questions

Which members of Congress have traded ATR?

Michael T. McCaul, Lisa C. McClain, Susie Lee, Lizzie Fletcher and Bradley Scott Schneider disclosed ATR transactions in the filings shown here.

How quickly are ATR trades disclosed?

Congressional disclosures took a median of 37 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days after the trade, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Oct 26, 2026.

Related companies

traded by the same members

See every company we track